Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791582 · ClinicalTrials.gov registry record
Pulse Oximetry- Evaluating Resp Rate- PCBA-1
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 27
- Enrollment target
NCT01791582: Completed study, sponsored by Medtronic - MITG.
NCT01791582 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01791582 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
To assess performance of resp rate parameter in a monitoring system PCBA-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-10 |
What the finished NCT01791582 record still lists
NCT01791582 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01791582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01791582 about?
NCT01791582 is a clinical study titled "Pulse Oximetry- Evaluating Resp Rate- PCBA-1". To assess performance of resp rate parameter in a monitoring system PCBA-1
What is the current status of trial NCT01791582?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2012-10. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT01791582?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia